IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis
Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathw...
Ausführliche Beschreibung
Autor*in: |
Brunner, Stefan M [verfasserIn] Schiechl, Gabriela [verfasserIn] Kesselring, Rebecca [verfasserIn] Martin, Maria [verfasserIn] Balam, Saidou [verfasserIn] Schlitt, Hans J [verfasserIn] Geissler, Edward K [verfasserIn] Fichtner-Feigl, Stefan [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: Transplantation research - London : Biomed Central, 2012, 2(2013), 1 vom: 22. Okt. |
---|---|
Übergeordnetes Werk: |
volume:2 ; year:2013 ; number:1 ; day:22 ; month:10 |
Links: |
---|
DOI / URN: |
10.1186/2047-1440-2-16 |
---|
Katalog-ID: |
SPR032215622 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR032215622 | ||
003 | DE-627 | ||
005 | 20230519143336.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/2047-1440-2-16 |2 doi | |
035 | |a (DE-627)SPR032215622 | ||
035 | |a (SPR)2047-1440-2-16-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Brunner, Stefan M |e verfasserin |4 aut | |
245 | 1 | 0 | |a IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. | ||
650 | 4 | |a IL-13 |7 (dpeaa)DE-He213 | |
650 | 4 | |a IL-13Rα |7 (dpeaa)DE-He213 | |
650 | 4 | |a TGF-β |7 (dpeaa)DE-He213 | |
650 | 4 | |a Allograft fibrosis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Heart transplantation |7 (dpeaa)DE-He213 | |
700 | 1 | |a Schiechl, Gabriela |e verfasserin |4 aut | |
700 | 1 | |a Kesselring, Rebecca |e verfasserin |4 aut | |
700 | 1 | |a Martin, Maria |e verfasserin |4 aut | |
700 | 1 | |a Balam, Saidou |e verfasserin |4 aut | |
700 | 1 | |a Schlitt, Hans J |e verfasserin |4 aut | |
700 | 1 | |a Geissler, Edward K |e verfasserin |4 aut | |
700 | 1 | |a Fichtner-Feigl, Stefan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transplantation research |d London : Biomed Central, 2012 |g 2(2013), 1 vom: 22. Okt. |w (DE-627)718830733 |w (DE-600)2668672-7 |x 2047-1440 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2013 |g number:1 |g day:22 |g month:10 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/2047-1440-2-16 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 2 |j 2013 |e 1 |b 22 |c 10 |
author_variant |
s m b sm smb g s gs r k rk m m mm s b sb h j s hj hjs e k g ek ekg s f f sff |
---|---|
matchkey_str |
article:20471440:2013----::l3inlnval3_tigrtf1eedn |
hierarchy_sort_str |
2013 |
publishDate |
2013 |
allfields |
10.1186/2047-1440-2-16 doi (DE-627)SPR032215622 (SPR)2047-1440-2-16-e DE-627 ger DE-627 rakwb eng 610 ASE Brunner, Stefan M verfasserin aut IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 Schiechl, Gabriela verfasserin aut Kesselring, Rebecca verfasserin aut Martin, Maria verfasserin aut Balam, Saidou verfasserin aut Schlitt, Hans J verfasserin aut Geissler, Edward K verfasserin aut Fichtner-Feigl, Stefan verfasserin aut Enthalten in Transplantation research London : Biomed Central, 2012 2(2013), 1 vom: 22. Okt. (DE-627)718830733 (DE-600)2668672-7 2047-1440 nnns volume:2 year:2013 number:1 day:22 month:10 https://dx.doi.org/10.1186/2047-1440-2-16 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2013 1 22 10 |
spelling |
10.1186/2047-1440-2-16 doi (DE-627)SPR032215622 (SPR)2047-1440-2-16-e DE-627 ger DE-627 rakwb eng 610 ASE Brunner, Stefan M verfasserin aut IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 Schiechl, Gabriela verfasserin aut Kesselring, Rebecca verfasserin aut Martin, Maria verfasserin aut Balam, Saidou verfasserin aut Schlitt, Hans J verfasserin aut Geissler, Edward K verfasserin aut Fichtner-Feigl, Stefan verfasserin aut Enthalten in Transplantation research London : Biomed Central, 2012 2(2013), 1 vom: 22. Okt. (DE-627)718830733 (DE-600)2668672-7 2047-1440 nnns volume:2 year:2013 number:1 day:22 month:10 https://dx.doi.org/10.1186/2047-1440-2-16 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2013 1 22 10 |
allfields_unstemmed |
10.1186/2047-1440-2-16 doi (DE-627)SPR032215622 (SPR)2047-1440-2-16-e DE-627 ger DE-627 rakwb eng 610 ASE Brunner, Stefan M verfasserin aut IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 Schiechl, Gabriela verfasserin aut Kesselring, Rebecca verfasserin aut Martin, Maria verfasserin aut Balam, Saidou verfasserin aut Schlitt, Hans J verfasserin aut Geissler, Edward K verfasserin aut Fichtner-Feigl, Stefan verfasserin aut Enthalten in Transplantation research London : Biomed Central, 2012 2(2013), 1 vom: 22. Okt. (DE-627)718830733 (DE-600)2668672-7 2047-1440 nnns volume:2 year:2013 number:1 day:22 month:10 https://dx.doi.org/10.1186/2047-1440-2-16 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2013 1 22 10 |
allfieldsGer |
10.1186/2047-1440-2-16 doi (DE-627)SPR032215622 (SPR)2047-1440-2-16-e DE-627 ger DE-627 rakwb eng 610 ASE Brunner, Stefan M verfasserin aut IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 Schiechl, Gabriela verfasserin aut Kesselring, Rebecca verfasserin aut Martin, Maria verfasserin aut Balam, Saidou verfasserin aut Schlitt, Hans J verfasserin aut Geissler, Edward K verfasserin aut Fichtner-Feigl, Stefan verfasserin aut Enthalten in Transplantation research London : Biomed Central, 2012 2(2013), 1 vom: 22. Okt. (DE-627)718830733 (DE-600)2668672-7 2047-1440 nnns volume:2 year:2013 number:1 day:22 month:10 https://dx.doi.org/10.1186/2047-1440-2-16 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2013 1 22 10 |
allfieldsSound |
10.1186/2047-1440-2-16 doi (DE-627)SPR032215622 (SPR)2047-1440-2-16-e DE-627 ger DE-627 rakwb eng 610 ASE Brunner, Stefan M verfasserin aut IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 Schiechl, Gabriela verfasserin aut Kesselring, Rebecca verfasserin aut Martin, Maria verfasserin aut Balam, Saidou verfasserin aut Schlitt, Hans J verfasserin aut Geissler, Edward K verfasserin aut Fichtner-Feigl, Stefan verfasserin aut Enthalten in Transplantation research London : Biomed Central, 2012 2(2013), 1 vom: 22. Okt. (DE-627)718830733 (DE-600)2668672-7 2047-1440 nnns volume:2 year:2013 number:1 day:22 month:10 https://dx.doi.org/10.1186/2047-1440-2-16 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2013 1 22 10 |
language |
English |
source |
Enthalten in Transplantation research 2(2013), 1 vom: 22. Okt. volume:2 year:2013 number:1 day:22 month:10 |
sourceStr |
Enthalten in Transplantation research 2(2013), 1 vom: 22. Okt. volume:2 year:2013 number:1 day:22 month:10 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
IL-13 IL-13Rα TGF-β Allograft fibrosis Heart transplantation |
dewey-raw |
610 |
isfreeaccess_bool |
true |
container_title |
Transplantation research |
authorswithroles_txt_mv |
Brunner, Stefan M @@aut@@ Schiechl, Gabriela @@aut@@ Kesselring, Rebecca @@aut@@ Martin, Maria @@aut@@ Balam, Saidou @@aut@@ Schlitt, Hans J @@aut@@ Geissler, Edward K @@aut@@ Fichtner-Feigl, Stefan @@aut@@ |
publishDateDaySort_date |
2013-10-22T00:00:00Z |
hierarchy_top_id |
718830733 |
dewey-sort |
3610 |
id |
SPR032215622 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR032215622</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143336.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2047-1440-2-16</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR032215622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2047-1440-2-16-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brunner, Stefan M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IL-13</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IL-13Rα</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">TGF-β</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Allograft fibrosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart transplantation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schiechl, Gabriela</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kesselring, Rebecca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martin, Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balam, Saidou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlitt, Hans J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geissler, Edward K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fichtner-Feigl, Stefan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Transplantation research</subfield><subfield code="d">London : Biomed Central, 2012</subfield><subfield code="g">2(2013), 1 vom: 22. Okt.</subfield><subfield code="w">(DE-627)718830733</subfield><subfield code="w">(DE-600)2668672-7</subfield><subfield code="x">2047-1440</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2047-1440-2-16</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield></datafield></record></collection>
|
author |
Brunner, Stefan M |
spellingShingle |
Brunner, Stefan M ddc 610 misc IL-13 misc IL-13Rα misc TGF-β misc Allograft fibrosis misc Heart transplantation IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
authorStr |
Brunner, Stefan M |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)718830733 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
2047-1440 |
topic_title |
610 ASE IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis IL-13 (dpeaa)DE-He213 IL-13Rα (dpeaa)DE-He213 TGF-β (dpeaa)DE-He213 Allograft fibrosis (dpeaa)DE-He213 Heart transplantation (dpeaa)DE-He213 |
topic |
ddc 610 misc IL-13 misc IL-13Rα misc TGF-β misc Allograft fibrosis misc Heart transplantation |
topic_unstemmed |
ddc 610 misc IL-13 misc IL-13Rα misc TGF-β misc Allograft fibrosis misc Heart transplantation |
topic_browse |
ddc 610 misc IL-13 misc IL-13Rα misc TGF-β misc Allograft fibrosis misc Heart transplantation |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Transplantation research |
hierarchy_parent_id |
718830733 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Transplantation research |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)718830733 (DE-600)2668672-7 |
title |
IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
ctrlnum |
(DE-627)SPR032215622 (SPR)2047-1440-2-16-e |
title_full |
IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
author_sort |
Brunner, Stefan M |
journal |
Transplantation research |
journalStr |
Transplantation research |
lang_code |
eng |
isOA_bool |
true |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
txt |
author_browse |
Brunner, Stefan M Schiechl, Gabriela Kesselring, Rebecca Martin, Maria Balam, Saidou Schlitt, Hans J Geissler, Edward K Fichtner-Feigl, Stefan |
container_volume |
2 |
class |
610 ASE |
format_se |
Elektronische Aufsätze |
author-letter |
Brunner, Stefan M |
doi_str_mv |
10.1186/2047-1440-2-16 |
dewey-full |
610 |
author2-role |
verfasserin |
title_sort |
il-13 signaling via il-$ 13rα_{2} $ triggers tgf-$ β_{1} $-dependent allograft fibrosis |
title_auth |
IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
abstract |
Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. |
abstractGer |
Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. |
abstract_unstemmed |
Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis |
url |
https://dx.doi.org/10.1186/2047-1440-2-16 |
remote_bool |
true |
author2 |
Schiechl, Gabriela Kesselring, Rebecca Martin, Maria Balam, Saidou Schlitt, Hans J Geissler, Edward K Fichtner-Feigl, Stefan |
author2Str |
Schiechl, Gabriela Kesselring, Rebecca Martin, Maria Balam, Saidou Schlitt, Hans J Geissler, Edward K Fichtner-Feigl, Stefan |
ppnlink |
718830733 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/2047-1440-2-16 |
up_date |
2024-07-04T02:46:29.950Z |
_version_ |
1803614882315108352 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR032215622</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143336.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2047-1440-2-16</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR032215622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2047-1440-2-16-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brunner, Stefan M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">IL-13 signaling via IL-$ 13Rα_{2} $ triggers TGF-$ β_{1} $-dependent allograft fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Allograft fibrosis still remains a critical problem in transplantation, including heart transplantation. The IL-13/TGF-$ β_{1} $ interaction has previously been identified as a key pathway orchestrating fibrosis in different inflammatory immune disorders. Here we investigate if this pathway is also responsible for allograft fibrosis and if interference with the IL-13/TGF-$ β_{1} $ interaction prevents allograft fibrosis. Methods FVB or control DBA/1 donor hearts were transplanted heterotopically into DBA/1 recipient mice and hearts were explanted at day 60 and 100 post-transplantation. Cardiac tissue was examined by Masson’s trichrome staining and immunohistochemistry for CD4, CD8, CD11b, IL-13, Fas ligand, matrix metalloproteinase (MMP)-1, MMP-13, β2-microglobulin, and Gremlin-1. Graft-infiltrating cells were isolated and analyzed by flow cytometry. IL-13 and TGF-$ β_{1} $ levels were determined by enzyme-linked immunosorbent assay (ELISA) and the amount of collagen was quantified using a Sircol assay; IL-$ 13Rα_{2} $ expression was detected by Western blotting. In some experiments IL-13/ TGF-$ β_{1} $ signaling was blocked with specific IL-$ 13Rα_{2} $ siRNA. Additionally, a PCR array of RNA isolated from the allografts was performed to analyze expression of multiple genes involved in fibrosis. Results Both groups survived long-term (>100 days). The allogeneic grafts were infiltrated by significantly increased numbers of $ CD4^{+} $ (P <0.0001), $ CD8^{+} $ (P <0.0001), and $ CD11b^{+} $ cells (P = 0.0065) by day 100. Furthermore, elevated IL-13 levels (P = 0.0003) and numbers of infiltrating IL-$ 13^{+} $ cells (P = 0.0037), together with an expression of IL-$ 13Rα_{2} $, were detected only within allografts. The expression of IL-13 and IL-$ 13Rα_{2} $ resulted in significantly increased TGF-$ β_{1} $ levels (P <0.0001), higher numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+ cells, and elevated cardiac collagen deposition (P = 0.0094). The allograft fibrosis found in these experiments was accompanied by upregulation of multiple profibrotic genes, which was confirmed by immunohistochemical stainings of allograft tissue. Blockage of the IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA led to lower numbers of $ CD11b^{high} %$ Gr1^{intermediate} $TGF-$ β_{1} $+, $ CD4^{+} $, $ CD8^{+} $, and $ CD11b^{+} $ cells, and prevented collagen deposition (P = 0.0018) within these allografts. Conclusions IL-13 signaling via IL-$ 13Rα_{2} $ induces TGF-$ β_{1} $ and causes allograft fibrosis in a murine model of chronic transplant rejection. Blockage of this IL-13/TGF-$ β_{1} $ interaction by IL-$ 13Rα_{2} $ siRNA prevents cardiac allograft fibrosis. Thus, IL-$ 13Rα_{2} $ may be exploitable as a future target to reduce allograft fibrosis in organ transplantation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IL-13</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IL-13Rα</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">TGF-β</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Allograft fibrosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart transplantation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schiechl, Gabriela</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kesselring, Rebecca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martin, Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balam, Saidou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlitt, Hans J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geissler, Edward K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fichtner-Feigl, Stefan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Transplantation research</subfield><subfield code="d">London : Biomed Central, 2012</subfield><subfield code="g">2(2013), 1 vom: 22. Okt.</subfield><subfield code="w">(DE-627)718830733</subfield><subfield code="w">(DE-600)2668672-7</subfield><subfield code="x">2047-1440</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2047-1440-2-16</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield></datafield></record></collection>
|
score |
7.3993816 |